Ecem Sevim profile image
Ecem Sevim
Publication 3 Review 0 CrossRef Cited 1
3 Publication
0 Review
1 CrossRef Cited

Institution

Publications

Rare Severe Coagulopathy Secondary Due to Dabigatran Use
Authors: Sema Uçak Basat , Ridvan Sivritepe , Damla Ortaboz , Ecem Sevim
Published: 2022 , Hitit Medical Journal
DOI: 10.52827/hititmedj.974085
FAVORITE 0 TOTAL DOWNLOAD COUNT 311

0

311

The relationship between prognostic and organ failure scoring systems and nutritional scores in geriatric patients in intensive care unit
Authors: Ridvan Sivritepe , Sema Uçak Basat , Okcan Basat , Oğuzhan Kara , Damla Ortaboz , Ecem Sevim , Arzu Baygül
Published: 2021 , Anatolian Journal of Health Research
DOI: 10.29228/anatoljhr.52893
FAVORITE 0 TOTAL DOWNLOAD COUNT 129

0

129

Olanzapine Induced Rhabdomyolysis in A Schizophrenic Adult: Case Report
Authors: Sema Uçak Basat , Ridvan Sivritepe , Damla Ortaboz , Ecem Sevim
Published: 2021 , Abant Medical Journal
DOI: 10.47493/abantmedj.1003768
FAVORITE 0 TOTAL DOWNLOAD COUNT 410

0

410

Articles published in
Abant Medical Journal
Abant Medical Journal
Anatolian Journal of Health Research
Anatolian Journal of Health Research
Hitit Medical Journal
Hitit Medical Journal
User doesn't have any peer review duties on DergiPark.

Publications

Olanzapine Induced Rhabdomyolysis in A Schizophrenic Adult: Case Report
Authors: Sema Uçak Basat , Ridvan Sivritepe , Damla Ortaboz , Ecem Sevim
Published: 2021 , Abant Medical Journal
DOI: 10.47493/abantmedj.1003768
CITED 1 FAVORITE 0 TOTAL DOWNLOAD COUNT 410

1

0

410

Popular Publications: It is determined automatically by the researchers doing research in DergiPark according to the statistics of being added to the favorites. CrossRef Cited: The citations shown in DergiPark are drawn from CrossRef. For this, the cited and cited articles must be registered in CrossRef (DOI number). ^: Citation numbers are reflected in the system by DergiPark at certain periods.
Interactive Guide Tool
If you want to see the panel introduction, you can click Start Tour.